Evaluation of Different Infant Vaccination Schedules Incorporating Pneumococcal Vaccination
Status: Active, no longer recruiting
Phase of Trial: Phase II/III
Latest Information Update: 10 Jun 2019
Price : $35 *
At a glance
- Drugs Pneumococcal 10-valent vaccine conjugate (Primary) ; Pneumococcal 13-valent CRM197 vaccine conjugate (Primary)
- Indications Pneumococcal infections
- Focus Pharmacodynamics
- 05 Jun 2019 Planned End Date changed from 1 Oct 2018 to 1 Dec 2019.
- 14 Jul 2017 Planned End Date changed from 1 May 2016 to 1 Oct 2018.
- 14 Jul 2017 Status changed from completed to active, no longer recruiting.